Divya Iyer leads growth initiatives at GoodRx to partner with biopharmaceutical companies. As a seasoned healthcare executive, she has evolved the Manufacturer Solutions team’s business strategy, and spearheads the strategy and execution of innovative solutions to drive access and affordability of brand medications. Her unique blend of scientific and business experience, along with her ability to consistently deliver results that improve patient outcomes, have earned her recognition as a thought leader in the industry. 

Previously, she was at McKesson where she led corporate strategy and M&A focused on their specialty and biopharma solutions group. She led the transformation of McKesson’s biopharma strategy and stood up a new oncology data and insights business. Prior to that, she worked at Deloitte as a management consultant, leading commercial strategy, corporate strategy, and portfolio management engagements for several pharmaceutical clients. She also worked at Merck in clinical development across multiple phases and therapeutic areas.

Divya holds a bachelor’s degree in Pharmacy, master's degree in Neuropharmacology and completed her MBA at the NYU Stern School of Business. In 2023, she was recognized by Medical Marketing + Media as a winner of its ’40 under 40’ award for ‘accomplished young talent working in and around medical marketing.’ She was also recognized as a Luminary by the Healthcare Businesswomen’s Association for her leadership and impact within GoodRx and the industry.